Suche

Anzeige der Dokumente 1-10 von 224

Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia

Wissenschaftlicher Artikel

Schlenk, R. F.; Frech, P.; Weber, D.; Brossart, P.; Horst, H-A; Kraemer, D.; Held, G.; Ringhoffer, M.; Burchardt, A.; Kobbe, G.; Goetze, K.; Nachbaur, D.; Fischer, T.; Luebbert, M.; Salih, H. R.; Salwender, H.; Wulf, G.; Koller, E.; Wattad, M.; Fiedler, W.; et al. (Universität Ulm, 2017)

RUNX1 mutations in acute myeloid leukemia

Dissertation

Teleanu, Maria-Veronica (Universität Ulm, 2017-06-16)

Acute myeloid leukemia (AML) is characterized by a great cytogenetic and molecular genetic diversity. Past years research has shed more light on the molecular background of the disease and identified new mutations and ...

All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study

Wissenschaftlicher Artikel

Schlenk, Richard F.; Luebbert, Michael; Benner, Axel; Lamparter, Alexander; Krauter, Juergen; Herr, Wolfgang; Martin, Hans; Salih, Helmut R.; Kuendgen, Andrea; Horst, Heinz-A.; Brossart, Peter; Goetze, Katharina; Nachbaur, David; Wattad, Mohammed; Koehne, Claus-Henning; Fiedler, Walter; Bentz, Martin; Wulf, Gerald; Held, Gerhard; Hertenstein, Bernd; et al. (Universität Ulm, 2016)

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

Wissenschaftlicher Artikel

Hallek, M.; Fischer, K.; Fingerle-Rowson, G.; Fink, A. M.; Busch, R.; Mayer, J.; Hensel, M.; Hopfinger, G.; Hess, G.; von Gruenhagen, U.; Bergmann, M.; Catalano, J.; Zinzani, P. L.; Caligaris-Cappio, F.; Seymour, J. F.; Berrebi, A.; Jaeger, U.; Cazin, B.; Trneny, M.; Westermann, A.; et al. (Universität Ulm, 2010)

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

Wissenschaftlicher Artikel

Hoelzer, Dieter; Walewski, Jan; Döhner, Hartmut; Viardot, Andreas; Hiddemann, Wolfgang; Spiekermann, Karsten; Serve, Hubert; Duehrsen, Ulrich; Huettmann, Andreas; Thiel, Eckhard; Dengler, Jolanta; Kneba, Michael; Schaich, Markus; Schmidt-Wolf, Ingo G. H.; Beck, Joachim; Hertenstein, Bernd; Reichle, Albrecht; Domanska-Czyz, Katarzyna; Fietkau, Rainer; Horst, Heinz-August; et al. (Universität Ulm, 2014)

Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy

Wissenschaftlicher Artikel

Huetter-Kroenke, Marie-Luise; Benner, Axel; Doehner, Konstanze; Krauter, Juergen; Weber, Daniela; Moessner, Margit; Koehne, Claus-Henning; Horst, Heinz A.; Schmidt-Wolf, Ingo G. H.; Rummel, Mathias; Goetze, Katharina; Koller, Elisabeth; Petzer, Andreas L.; Salwender, Hans; Fiedler, Walter; Kirchen, Heinz; Haase, Detlef; Kremers, Stephan; Theobald, Matthias; Matzdorff, Axel C.; et al. (Universität Ulm, 2016)

Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia

Wissenschaftlicher Artikel

Kienle, Dirk; Benner, Axel; Laeufle, Carolin; Winkler, Dirk; Schneider, Christof; Buehler, Andreas; Zenz, Thorsten; Habermann, Annett; Jaeger, Ulrich; Lichter, Peter; Dalla-Favera, Riccardo; Döhner, Hartmut; Stilgenbauer, Stephan (Universität Ulm, 2010)

BRAF mutations in chronic lymphocytic leukemia

Wissenschaftlicher Artikel

Jebaraj, Billy Michael Chelliah; Kienle, Dirk; Buehler, Andreas; Winkler, Dirk; Döhner, Hartmut; Stilgenbauer, Stephan; Zenz, Thorsten (Universität Ulm, 2013)

Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy

Wissenschaftlicher Artikel

Herling, Carmen Diana; Klaumuenzer, Marion; Rocha, Cristiano Krings; Altmueller, Janine; Thiele, Holger; Bahlo, Jasmin; Kluth, Sandra; Crispatzu, Giuliano; Herling, Marco; Schiller, Joanna; Engelke, Anja; Tausch, Eugen; Döhner, Hartmut; Fischer, Kirsten; Goede, Valentin; Nuernberg, Peter; Reinhardt, Hans Christian; Stilgenbauer, Stephan; Hallek, Michael; Kreuzer, Karl-Anton (Universität Ulm, 2016)

Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

Wissenschaftlicher Artikel

Döhner, Hartmut; Luebbert, Michael; Fiedler, Walter; Fouillard, Loic; Haaland, Alf; Brandwein, Joseph M.; Lepretre, Stephane; Reman, Oumedaly; Turlure, Pascal; Ottmann, Oliver G.; Mueller-Tidow, Carsten; Kraemer, Alwin; Raffoux, Emmanuel; Doehner, Konstanze; Schlenk, Richard F.; Voss, Florian; Taube, Tillmann; Fritsch, Holger; Maertens, Johan (Universität Ulm, 2014)

1
2
3
4
. . .
23

Suche

Filter